Showing results (1031-1040 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|November 15, 2025
Complications and mortality of typhoid fever: an updated global systematic review and meta-analysisShruti Murthy, Nienke N Hagedoorn, Suzanne Faigan, et al.
The Lancet. Infectious Diseases|November 15, 2025
Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy studyBarnabas Bakamutumaho, David Lupande Mwenebitu, Winters Muttamba, et al.
The Lancet. Infectious Diseases|November 10, 2025
Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort studyChristophe Van Dijck, Nicole Berens-Riha, Luca M Zaeck, et al.
The Lancet. Infectious Diseases|November 10, 2025
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trialLaura Wagner, Michaela Obersriebnig, Romana Hochreiter, et al.
The Lancet. Infectious Diseases|September 20, 2025
Breaking the under-reporting cycle for zoonotic diseases in low-income and middle-income countries through national-level integration of community-based surveillance and response: insights from Cameroon, Chad, Côte d'Ivoire, and MaliKatherine E L Worsley-Tonks, Mahamat Fayiz Abakar, Zanan Coulibaly, et al.
The Lancet. Infectious Diseases|August 9, 2025
Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022-23): a prospective, multicentre, longitudinal, immunoepidemiological surveillance studyHai Nguyen-Tran, Sang Woo Park, Matthew R Vogt, et al.
The Lancet. Infectious Diseases|September 19, 2025
Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trialSelidji T Agnandji, Jeroen Bok, Ayodele Alabi, et al.
The Lancet. Infectious Diseases|October 13, 2025
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, Phrutsamon Wongnak, et al.
The Lancet. Infectious Diseases|September 17, 2013
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studiesBenoit Witkowski, Chanaki Amaratunga, Nimol Khim, et al.
The Lancet. Infectious Diseases|July 22, 2014
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort studyNick J Andrews, Pauline A Waight, Polly Burbidge, et al.
Pageof 270